Reported results
- Net income was $165.239 million for Q3 2026.
- Adjusted EBITDAX was $294 million for Q3 2026.
- Operating Margin was 32% for Q3 2026.
- Cash Operating Margin was 62% for Q3 2026.
- Free Cash Flow was $125 million for Q3 2026.
Guidance
- 2026E Production Volumes: 612.5 - 617.5 Bcfe
- 2026E Adjusted EBITDAX: $1,290 - $1,310 million
- 2026E Total Capital Expenditures: 571 - 586 million
- 2026E Free Cash Flow: ~$550 million
Notes
CNX is unable to provide a reconciliation of non-GAAP projected financial results to their respective comparable financial measure calculated in accordance with GAAP.
Price and volatility reaction
The stock moved -3.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -6.3 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 38.05 | 2026-10-28 |
| Close after release | 36.79 | 2026-10-29 |
| Realised move | -3.3% | close to close |
| 30d ATM IV change | -6.3 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.
